A phase Ib study of the safety and efficacy of atezolizumab (atezo) + bevacizumab (bev) + cobimetinib (cobi) in patients (pts) with metastatic colorectal cancer (mCRC) Meeting Abstract
| Authors: | Bendell, J.; Lieu, C.; Raghav, K. P. S.; Argilés, G.; Cubillo, A.; Qu, X.; Yan, Y.; Merchant, M.; Zeuner, H.; Gallo, J. D.; Segal, N. H. |
| Abstract Title: | A phase Ib study of the safety and efficacy of atezolizumab (atezo) + bevacizumab (bev) + cobimetinib (cobi) in patients (pts) with metastatic colorectal cancer (mCRC) |
| Meeting Title: | 44th ESMO Congress (ESMO 2019) |
| Journal Title: | Annals of Oncology |
| Volume: | 30 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2019 Sep 27-Oct 1 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2019-10-01 |
| Start Page: | mdz246.080 |
| Language: | English |
| ACCESSION: | WOS:000491295502034 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdz246.080 |
| Notes: | Meeting Abstract: 603P -- Appears on pages v227-v228 of the abstract book -- Source: Wos |
